Key facts
- It has raised $3.3M; the latest was PE Growth/Expansion in Feb 2026.
- Notable investors include Climate Capital, Third Derivative, The Engine, Activate Global, Pillar VC — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Wild Microbes
- ·The full record, as it builds
Funding rounds
No funding rounds for Wild Microbes are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wild Microbes
Developer of a microbial platform designed for producing sustainable chemicals, ingredients, and materials. The company's platform utilizes synthetic biology to modify microbes and leverages its expertise in cultivating and engineering, enabling various industries to adopt more sustainable practices.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2021
- Employees
- 11
- Website
- wildmicrobes.com/
- Ownership
- Privately Held (backing)
Wild Microbes doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wild Microbes shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wild Microbes in its N-PORT filings yet. We sweep new filings monthly.